|
| Pirarubicin Basic information |
Product Name: | Pirarubicin | Synonyms: | THP-ADM;THEPRUBICIN;(8s-cis)-droxyacetyl)-1-methoxy;(8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;Tepirubicin;Therarubiein;THP-adriamycin;(8S,10S)-10-[(2S,4S,5S,6S)-4-Amino-6-methyl-5-[(2S)-oxan-2-yl]oxy-oxan-2-yl]oxy-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7H-tetracene-5,12-dione | CAS: | 72496-41-4 | MF: | C32H37NO12 | MW: | 627.64 | EINECS: | | Product Categories: | Inhibitors;API;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals | Mol File: | 72496-41-4.mol | |
| Pirarubicin Chemical Properties |
Melting point | 188-192°C (dec.) | alpha | D25 +175 ±25° (c = 0.2 in CHCl3) | Boiling point | 834.7±65.0 °C(Predicted) | density | 1.51±0.1 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | ethanol: soluble25mg/mL | pka | 7.35±0.60(Predicted) | form | powder | color | Orange to Red | Stability: | Hygroscopic |
Hazard Codes | Xi | Risk Statements | 36/37/38 | Safety Statements | 26-37/39 | WGK Germany | 3 | RTECS | QI9296000 | Toxicity | LD50 i.v. in mice: 27.8 mg/kg (Umezawa, 1979) |
| Pirarubicin Usage And Synthesis |
Description | Pirarubicin is a new anthracycline anticancer agent structurally related to doxorubicin. In
acute leukemia, non-Hodgkin’s lymphoma, breast and ovariail carcinoma, pirarubicin is
reportedly superior to doxorubicin and better tolerated. Its major side-effect appears to be
myelosuppression, mainly in the form of leucopenia, which is potentially dose-limiting. | Chemical Properties | Red Solid | Originator | Meiji Seika (Japan) | Uses | Structural analog of Doxorubicin. Antineoplastic. | Definition | ChEBI: (7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-6-methyl-5-[[(2R)-2-oxanyl]oxy]-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione is an anthracycline. | Brand name | Pinorubicin; Therarubucin |
| Pirarubicin Preparation Products And Raw materials |
|